Page 52 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 1 The Etiology of Cancer 31

215. White RA, Jefferies AR, Gorman NT: Sarcoma development fol- 238. Brodey RS, Goldschmidt MH, Roszel JR: Canine mammary gland
lowing irradiation of acanthomatous epulis in two dogs, Vet Rec neoplasms, J Am Anim Hosp Assoc 19:61–90, 1983.
118:668, 1986. 239. Perez Alenza MD, Peña L, Del Castillo N, et al.: Factors influenc-
VetBooks.ir 216. McChesney SL, Withrow SJ, Gillette EL, et al.: Radiotherapy of ing the incidence and prognosis of canine mammary tumours, J
Small Anim Pract 41:287–291, 2000.
soft tissue sarcomas in dogs, J Am Vet Med Assoc 194:60–63, 1989.
217. Gillette SM, Gillette EL, Powers BE, et al.: Radiation-induced
osteosarcoma in dogs after external beam or intraoperative radia- 240. Beauvais W, Cardwell JM, Brodbelt DC: The effect of neutering on
the risk of mammary tumours in dogs—a systematic review, J Small
tion therapy, Cancer Res 50:54–57, 1990. Anim Pract 53:314–322, 2012.
218. Patel TR, Chiang VL: Secondary neoplasms after stereotactic radio- 241. Kristiansen VM, Nodtvedt A, Breen AM, et al.: Effect of ovariohys-
surgery, World Neurosurg 81:594–599, 2014. terectomy at the time of tumor removal in dogs with benign mam-
219. Lewis CG, Sunderman FW: Metal carcinogenesis in total mary tumors and hyperplastic lesions: a randomized controlled
joint arthroplasty: animal models, Clin Orthop Relat Res clinical trial, J Vet Intern Med 27:935–942, 2013.
329(Suppl):S264–S268, 1996. 242. Kristiansen VM, Pena L, Diez Cordova L, et al.: Effect of ovar-
220. Li XQ, Hom DL, Black J: Relationship between metallic implants iohysterectomy at the time of tumor removal in dogs with mam-
and cancer: a case-control study in a canine population, Vet Comp mary carcinomas: a randomized controlled trial, J Vet Intern Med
Orthop Traumatol 6:70–74, 1993. 30:230–241, 2016.
221. Selmic LE, Ryan SD, Boston SE, et al.: Osteosarcoma following 243. Panko WB, Patnaik AK, Harvey HJ, et al.: Estrogen receptors in
tibial plateau leveling osteotomy in dogs: 29 cases (1997-2011), J canine mammary tumors, Cancer Res 42:2255–2259, 1982.
Am Vet Med Assoc 244:1053–1059, 2014. 244. Mialot JP, Andre F, Martin PH, et al.: Etude de recepteurs des
222. Arthur EG, Arthur GL, Keeler MR, et al.: Risk of osteosarcoma in hormones steroides dans les tumeurs mammaires de la chienne. II.
dogs after open fracture fixation, Vet Surg 45:30–35, 2016. Correlations avec quelques caracteristques cliniques, Rec Med Vet
223. Sartor AJ, Ryan SD, Sellmeyer T, et al.: Bi-institutional retrospec- 158:513–521, 1982.
tive cohort study evaluating the incidence of osteosarcoma fol- 245. Monson KR, Malbica JO, Hubben K: Determination of estrogen
lowing tibial plateau levelling osteotomy (2000-2009), Vet Comp receptors in canine mammary tumors, Am J Vet Res 38:1937–1939,
Orthop Traumatol 27:339–345, 2014. 1977.
224. Gilley RS, Hiebert E, Clapp K, et al.: Long-term formation of 246. Donnay I, Rauïs J, Devleeschouwer N, et al.: Comparison of estro-
aggressive bony lesions in dogs with mid-diaphyseal fractures sta- gen and progesterone receptor expression in normal and tumor
bilized with metallic plates: incidence in a tertiary referral hospital mammary tissues from dogs, Am J Vet Res 56:1188–1194, 1995.
population, Front Vet Sci 4:3, 2017. 247. Elling H, Ungemach FR: Simultaneous occurrence of receptors for
225. Burton AG, Johnson EG, Vernau W, et al.: Implant-associated estradiol, progesterone, and dihydrotestosterone in canine mam-
neoplasia in dogs: 16 cases (1983-2013), J Am Vet Med Assoc mary tumors, J Cancer Res Clin Oncol 105:231–237, 1983.
247:778–785, 2015. 248. Sartin EA, Barnes S, Kwapien RP, et al.: Estrogen and progesterone
226. Rowland PH, Moise NS, Severson D: Myxoma at the site of a sub- receptor status of mammary carcinomas and correlation with clini-
cutaneous pacemaker in a dog, J Am Anim Hosp Assoc 27:649–651, cal outcome in dogs, Am J Vet Res 53:2196–2200, 1992.
1991. 249. Rutteman GR, Misdorp W, Misdorp W, et al.: OEstrogen (ER)
227. Pardo AD, Adams WH, McCracken MD, et al.: Primary jejunal and progestin receptors (PR) in mammary tissue of the female dog:
osteosarcoma associated with a surgical sponge in a dog, J Am Vet different receptor profile in non-malignant and malignant states, Br
Med Assoc 196:935–938, 1990. J Cancer 58:594–599, 1988.
228. Corbin EE, Cavanaugh RP, Fick JL, et al.: Foreign body reaction 250. Rutteman GR: Hormones and mammary tumour disease in the
to a retained surgical sponge (gossypiboma) mimicking an implant female dog: an update, In Vivo 4:33–40, 1990.
associated sarcoma in a dog after a tibial plateau levelling osteot- 251. Støvring M, Moe L, Glattre E: A population-based case-control
omy, Vet Comp Orthop Traumatol 26:147–153, 2013. study of canine mammary tumours and clinical use of medroxy-
229. Rayner EL, Scudamore CL, Francis I, et al.: Abdominal fibrosar- progesterone acetate, APMIS 105:590–596, 1997.
coma associated with a retained surgical swab in a dog, J Comp 252. Zanninovic P, Simcic V: Epidemiology of mammary tumors in
Pathol 143:81–85, 2010. dogs, Eur J Comp Anim Pract 4:67–76, 1994.
230. Thieman Mankin KM, Dunbar MD, Toplon D, et al.: Rhabdo- 253. Lantinga-van Leeuwen IS, Van Garderen E, Rutteman GR, et al.:
myosarcoma associated with the lead wire of a pacemaker generator Cloning and cellular localization of the canine progesterone recep-
implant, Vet Clin Pathol 43:276–280, 2014. tor: co-localization with growth hormone in the mammary gland, J
231. Orenstein MR, Schenker MB: Environmental asbestos exposure Steroid Biochem Mol Biol 75:219–228, 2000.
and mesothelioma, Curr Opin Pulm Med 6:371–377, 2000. 254. Mol JA, Lantinga-van Leeuwen I, Van Garderen E, et al.: Progestin-
232. Glickman LT, Domanski LM, Maguire TG, et al.: Mesothelioma induced mammary growth hormone (GH) production, Adv Exp
in pet dogs associated with exposure of their owners to asbestos, Med Biol 480:71–76, 2000.
Environ Res 32:305–313, 1983. 255. Rijnberk A, Kooistra HS, Mol JA: Endocrine diseases in dogs and
233. Harbison ML, Godleski JJ: Malignant mesothelioma in urban cats: Similarities and differences with endocrine diseases in humans,
dogs, Vet Pathol 20:531–540, 1983. Growth Horm IGF Res 13:S158–S164, 2003.
234. Machida N, Tanaka R, Takemura N, et al.: Development of peri- 256. Hayes HM, Milne KL, Mandell CP: Epidemiological features of
cardial mesothelioma in golden retrievers with a long-term history feline mammary carcinoma, Vet Rec 108:476–479, 1981.
of idiopathic haemorrhagic pericardial effusion, J Comp Pathol 257. Misdorp W, Romijn A, Hart AAM: Feline mammary tumors: a
131:166–175, 2004. case-control study of hormonal factors, Anticancer Res 11:1793–
235. Smith AN: The role of neutering in cancer development, Vet Clin 1797, 1991.
North Am Small Anim Pract 44:965–975, 2014. 258. Overley B, Shofer FS, Goldschmidt MH, et al.: Association
236. Moulton JE: Tumors of the mammary gland. In Moulton JE, edi- between ovarihysterectomy and feline mammary carcinoma, J Vet
tor: Tumors in domestic animals, ed 3, Berkley, CA, 1990, Univer- Intern Med 19:560–563, 2005.
sity of California Press, pp 518–552. 259. National Cancer Institute: Surveillance, epidemiology, and end
237. Schneider R, Dorn CR, Taylor DON: Factors influencing canine results program public use data, (1973-2000), Bethesda, MD.
mammary cancer development and postsurgical survival, J Natl 2003.
Cancer Inst 43:1249–1261, 1969.